These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38914352)
1. Design and evaluation of oseltamivir phosphate dual-phase extended-release tablets for the treatment of influenza. Yu L; Huang X; Jiang M; Guo W; Li X; Huang F; You J Int J Pharm; 2024 Aug; 661():124364. PubMed ID: 38914352 [TBL] [Abstract][Full Text] [Related]
2. Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies. Klančar U; Baumgartner S; Legen I; Smrdel P; Kampuš NJ; Krajcar D; Markun B; Kočevar K AAPS PharmSciTech; 2015 Apr; 16(2):398-406. PubMed ID: 25331194 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate. Pradhan R; Kim YI; Chang SW; Kim JO Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032 [TBL] [Abstract][Full Text] [Related]
4. Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays. Venkatesh DN; Meyyanathan SN; Kovacevic A; Zielińska A; Fonseca J; Eder P; Dobrowolska A; Souto EB Molecules; 2022 Oct; 27(19):. PubMed ID: 36235026 [TBL] [Abstract][Full Text] [Related]
5. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings. Lee BJ; Ryu SG; Cui JH Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084 [TBL] [Abstract][Full Text] [Related]
6. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets. Ali R; Dashevsky A; Bodmeier R Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241 [TBL] [Abstract][Full Text] [Related]
7. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture. Van Nguyen H; Nguyen VH; Lee BJ Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034 [TBL] [Abstract][Full Text] [Related]
8. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet. Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697 [TBL] [Abstract][Full Text] [Related]
9. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers. Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663 [TBL] [Abstract][Full Text] [Related]
10. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet. Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504 [TBL] [Abstract][Full Text] [Related]
11. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate. Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228 [TBL] [Abstract][Full Text] [Related]
12. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability. Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268 [TBL] [Abstract][Full Text] [Related]
13. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets. Vemula SK AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285 [TBL] [Abstract][Full Text] [Related]
14. Design and study of lamivudine oral controlled release tablets. Ravi PR; Ganga S; Saha RN AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522 [TBL] [Abstract][Full Text] [Related]
15. Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability. Badshah A; Subhan F; Rauf K; Bukhari NI; Shah K; Khan S; Ahmed Z; Khan I AAPS PharmSciTech; 2011 Jun; 12(2):525-33. PubMed ID: 21494924 [TBL] [Abstract][Full Text] [Related]
16. The performance of HPMC matrix tablets using various agglomeration manufacturing processes. Košir D; Vrečer F Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880 [TBL] [Abstract][Full Text] [Related]
17. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Barakat NS; Elbagory IM; Almurshedi AS Drug Deliv; 2009 Jan; 16(1):57-65. PubMed ID: 19555310 [TBL] [Abstract][Full Text] [Related]
18. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics. Saravanan M; Sri Nataraj K; Ganesh KS Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240 [TBL] [Abstract][Full Text] [Related]
19. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam. Mahaguna V; Talbert RL; Peters JI; Adams S; Reynolds TD; Lam FY; Williams RO Eur J Pharm Biopharm; 2003 Nov; 56(3):461-8. PubMed ID: 14602191 [TBL] [Abstract][Full Text] [Related]
20. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Ravi PR; Ganga S; Saha RN Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]